PRACTICE OF USING VIRAL PROTEASE INHIBITORS IN CHILDREN WITH HIV INFECTION
Selection of the most effective and safest high-active antiretroviral therapies is a critical issue faced by modern HIV medicine. Authors studied 28 children with HIV infection aged from 3 to 7 divided into two groups administered a combination of two HIV reverse transcriptase nucleoside inhibitors...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Paediatrician Publishers, LLC
2010-02-01
|
Series: | Pediatričeskaâ Farmakologiâ |
Online Access: | https://www.pedpharma.ru/jour/article/view/1198 |